The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 9, 1996, Pages 3299-3306

  Dunaif, Andrea ^a,d   Scott, Denise ^a   Finegood, Diane ^b   Quintana, Benjamin ^a   Whitcomb, Randall ^c  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c PFIZER INC   (United States)

^d PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTRONE; PRASTERONE; TROGLITAZONE;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE TOLERANCE; HORMONE BINDING; HORMONE RESPONSE; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; MENSTRUAL CYCLE; METABOLIC REGULATION; ORAL DRUG ADMINISTRATION; OVARY POLYCYSTIC DISEASE; OVULATION; PATHOGENESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPRODUCTION; STEROIDOGENESIS;

ADULT; BODY MASS INDEX; CHROMANS; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; DOUBLE-BLIND METHOD; ESTRADIOL; ESTRONE; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; POLYCYSTIC OVARY SYNDROME; REGRESSION ANALYSIS; TESTOSTERONE; THIAZOLES; THIAZOLIDINEDIONES;

EID: 0029795871     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.9.3299     Document Type: Article

References (14)

1. Polson DW, Wadsworth J, Adams J, Franks S. 1988 Polycystic ovaries-a common finding in normal women. Lancet. 1:870-872.
2. Hull MGR. 1987 Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol Endocrinol. 1:235-245.
3. Franks S. 1995 Polycystic ovary syndrome. N Engl J Med. 333:853-861.
4. Dunaif A. 1992 Insulin resistance and ovarian dysfunction. The Endocrinologist. 2:248-260.
5. Burghen GA, Givens JR, Kitabchi AE. 1980 Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab. 50:113-116.
6. Dunaif A, Graf M, Mandeli J, Laumas V, Dobrjansky A. 1987 Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab. 65:499-507.
7. Dunaif A, Futterweit W, Segal KR, Dobrjansky A. 1989 Profound peripheral insulin resistance, independent of obesity, in the polycystic ovary syndrome. Diabetes. 38:1165-1174.
8. Dunaif A, Graf M. 1989 Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome. J Clin Invest. 83:23-29.
9. Nestler JE, Barlascini CO, Matt DW. 1989 Suppression of serum insulin by diazoxide reduced serum testosterone levels in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 68:1027.
10. Prelevic GM, Wurzburger MI, Balint-Peric L, Nesic JS. 1990 Inhibitory effect of sandostatin on secretion of luteinizing hormone and ovarian steroids in polycystic ovary syndrome. Lancet. 336:900-903.
11. Bailey CJ. 1993 Metformin - an update. Gen Pharmacol. 24:1299-1309.
12. Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J. 1994 Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med. 331:1188-1193.
13. . 13. DeFronzo RA, Ferrannini E. 1991 Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 14:173-194.
14. Stumvoll M, Nurjhan N, Perriello G, Dailey G, Gerich JE. 1995 Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med. 333:550-554.